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The incidence of parasuicide among the unemployed, however, always remained dramatically higher than among the employed and only once in the years 1976-82 was the relative risk less than 10-fold (table I) . For clarity we would emphasise that the decline in the incidence of parasuicide among the unemployed has been more than offset by the increase in their numbers. The population attributable risk has shown a tendency to rise in line with the upward trend in unemployment despite the decline in relative risk (table I) , and the proportion of the overall rate attributable to unemployment increased from 36-5% in 1979 to 57-8% in 1982 (table I) . We will shortly report more detailed estimates.
Our third notable finding was the role of long term unemployment. After one year the risk approached double 
() (12) however, the prevalence rose to only 8-7% as opposed to the 13% that would have been expected had the trend from earlier years been maintained. The introduction of spectinomycin in January 1983 was followed by a steady fall in the monthly isolation rate of the strain during the first half of that year (fig 2) . Unlike in Los Angeles this was not maintained. 8 The question therefore arose whether spectinomycin resistance in penicillinase producing N gonorrhoeae, first seen at the hospital in 1981, had contributed to our failure to influence the prevalence of the strain to a greater degree.
Although eight spectinomycin resistant strains of penicillinase producing Ngonorrhoeae (3% of all isolates) had been seen before the introduction of spectinomycin as first line treatment, a further 14 patients (5%) infected with these strains were seen during 1983. The table gives the details ofthese patients. In 11 ofthe 22 patients resistant strains were isolated after initial spectinomycin treatment in our clinic, for nine of which pretreatment isolates were known to be sensitive to spectinomycin. In 11 patients a spectinomycin resistant strain was isolated at their first visit to the clinic before treatment. Five of these patients were known sexual contacts of patients with gonorrhoea caused by spectinomycin resistant penicillinase producing N gonorrhoeae.
We have also encountered spectinomycin resistance in nonpenicillinase-producing Ngonorrhoeae. Before we changed to spectinomycin the incidence of resistance in non-penicillinase-producing N gonorrhoeae was unknown, as until then we had screened only penicillinase producing N gonorrhoeae. During 1983 we tested 2933 isolates of non-penicillinase-producing N gonorrhoeae and detected six that were resistant to spectinomycin (0 2%), although the first example was not seen until August. Since January 1984 we have isolated a further eight spectinomycin resistant strains of non-penicillinaseproducing N gonorrhoeae. All the spectinomycin resistant N gonorrhoeae required proline for growth and carried the 2-6 and 24 5 megadalton plasmids. The penicillinase producers also carried the 4-4 megadalton plasmid. All strains showed high level resistance to spectinomycin (>. 512 mg/l). Two of these were not detected on initial screening with a 100 ,ug spectinomycin disc, and the other resistant strains grew up to the disc. Serological studies showed that all spectinomycin resistant N gonorrhoeae tested were indistinguishable. The serovar was Bacjk.
Despite the biological similarity among the strains they were isolated over a long period, and, although three contact pairs were seen, no clear overall epidemiological pattern was evident.
Clinical failure with spectinomycin that could not be accounted for by spectinomycin resistance occurred in 5%0 of patients, a figure compatible with other treatment regimens employed at the clinic.9
Discussion
The change from oral treatment to intramuscular spectinomycin did not prove to be a major problem, and by September 1983 some 85% of heterosexual patients with gonorrhoea were receiving spectinomycin. In common with others we have isolated few examples of penicillinase producing N gonorrhoeae (14/588) from male homosexuals10 and consequently ampicillin and probenecid remained first line treatment for these patients. Some 2000 patients received spectinomycin in 1983.
In Los Angeles the introduction of spectinomycin combined with intensive epidemiological back up had a spectacular effect in reducing the prevalence of infections with penicillinase producing Ngonorrhoeae. 8 We have seen no such effect, but there are important differences between the two settings. Firstly, the Praed Street Clinic is only one of many clinics in London for sexually transmitted diseases. Patients have ready access to all public clinics and can and do go from one to another. In this setting a change in treatment in one clinic, albeit the largest one, can have only a limited effect. Secondly, we do not have the financial resources to carry out intensive epidemiological work on the scale done in Los Angeles. We believe that this aspect is at least as important as the introduction of a penicillinase stable antibiotic.
If spectinomycin has not caused a dramatic fall in the prevalence of penicillinase producing Ngonorrhoeae, has it prevented a dramatic rise ? The increase in numbers of penicillinase producing N gonorrhoeae isolated yearly did slow down in 1983 after the dramatic rise during the previous five years. A similar pattern, however, was evident in the figures for penicillinase producing Ngonorrhoeae isolated in England and Wales. During July to December 1983 there were 599 isolates of penicillinase producing Ngonorrhoeae reported to the Communicable Disease Surveillance Centre. This compares with 624 in the preceding six months and 613 during July to December 1982.1" It will be several months, however, before we know whether the same is true world wide.
Spectinomycin resistance in both penicillinase producing and non-penicillinase-producing gonococci has been a worrying development, but despite sporadic reports in Britain and a cluster of cases in Korea there is no evidence of dissemination of strains world wide. Although our early isolates of penicillinase producing N gonorrhoeae were all directly linked to spectinomycin treatment, we have since seen the apparent transmission of these organisms. Microbiological evidence suggests that we are dealing with a single clone of organisms, but we lack the epidemiological information to link them. Apart from possession of the 4-4 megadalton plasmid coding for penicillinase production, all the spectinomycin resistant Ngonorrhoeae are so similar that they may well have a common source. This might be either a strain of penicillinase producing N gonorrhoeae that has lost its 4-4 plasmid or a strain of non-penicillinase-producing N gonorrhoeae that has gained it. The serological evidence also supports a common source. It is also possible, howeverthough highly unlikely-that we are observing a series of unconnected events.
We changed to spectinomycin as first line treatment using the principle suggested by McCutchan 
